SWOT Analysis for NeuroPace Inc

MACD Crossover Above Signal Line
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Relative Outperformance versus Industry over the Quarter (3 Months)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
MACD crossed above signal line previous end of day
Increasing Revenue every Quarter for the past 4 Quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Increasing profits every quarter for the past 3 quarters
Top Gainers
Stock with Low PE (PE < = 10)
Volume Shockers
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects
Momentum Trap (DVM)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years